Endocrine Disruptor assessment for (3E)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one concluded
On 12 April 2023, an assessment for the following substance on ECHA's Endocrine Disruptor Assessment List concluded:
Previous
Previous
Final IRIS Assessment published
Next
Next